Heart Rhythm, ISSN 1547-5271, 2014, Volume 11, Issue 7, pp. 1304 - 1323
Cardiovascular | Immunosuppression | Atrial arrhythmias | Sarcoidosis | Heart block | Catheter ablation | Risk stratification | Ventricular tachycardia | Implantable cardioverter-defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | PROGRAMMED VENTRICULAR STIMULATION | COLLEGE-OF-CARDIOLOGY | Heartblock | ATRIAL-FIBRILLATION | POSITRON-EMISSION-TOMOGRAPHY | NONISCHEMIC CARDIOMYOPATHY | CORTICOSTEROID-THERAPY | HEART-ASSOCIATION | ACCF/AHA/HRS FOCUSED UPDATE | ENDOMYOCARDIAL BIOPSY | Sarcoidosis - diagnosis | Sarcoidosis - therapy | Arrhythmias, Cardiac - therapy | Humans | Cardiomyopathies - diagnosis | Arrhythmias, Cardiac - diagnosis | Cardiomyopathies - therapy | Medical colleges | Care and treatment | Diagnosis | Arrhythmia
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2015, Volume 31, Issue 12, pp. 1418 - 1420
Cardiovascular | WOMEN | CARDIAC & CARDIOVASCULAR SYSTEMS | BROMOCRIPTINE | CLINICAL-TRIALS | POSTPARTUM | OUTCOMES | SUPPRESSION | EPIDEMIOLOGY | Cardiomyopathies - drug therapy | Pregnancy | Puerperal Disorders - drug therapy | Pregnancy Complications, Cardiovascular - drug therapy | Humans | Hydrazones - therapeutic use | Female | Bromocriptine - therapeutic use | Pentoxifylline - therapeutic use | Pyridazines - therapeutic use
Journal Article
JACC: Heart Failure, ISSN 2213-1779, 2015, Volume 3, Issue 12, pp. 998 - 1000
Journal Article
Heart Rhythm, ISSN 1547-5271, 2010, Volume 7, Issue 4, pp. 445 - 451
Background Minimally invasive thoracoscopic procedures have evolved for surgical treatment of atrial fibrillation (AF). The spectrum and management of...
Cardiovascular | Surgical ablation | Atrial fibrillation | Catheter ablation | TACHYARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | SITES | MECHANISMS | Recurrence | Humans | Middle Aged | Atrial Fibrillation - etiology | Female | Male | Aged | Pulmonary Veins - surgery | Catheter Ablation - adverse effects | Atrial Fibrillation - surgery | Atrial Flutter - etiology | Minimally Invasive Surgical Procedures
Cardiovascular | Surgical ablation | Atrial fibrillation | Catheter ablation | TACHYARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | SITES | MECHANISMS | Recurrence | Humans | Middle Aged | Atrial Fibrillation - etiology | Female | Male | Aged | Pulmonary Veins - surgery | Catheter Ablation - adverse effects | Atrial Fibrillation - surgery | Atrial Flutter - etiology | Minimally Invasive Surgical Procedures
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 5, pp. 491 - 492
Journal Article
Heart Failure Clinics, ISSN 1551-7136, 10/2007, Volume 3, Issue 4, pp. 511 - 518
Congestive heart failure affects 5 million patients each year and is more common in elderly patients. Cardiac resynchronization therapy (CRT) or biventricular...
Journal Article
Clinics in Geriatric Medicine, ISSN 0749-0690, 02/2007, Volume 23, Issue 1, pp. 193 - 203
Congestive heart failure affects 5 million patients each year and is more common in elderly patients. Cardiac resynchronization therapy (CRT) or biventricular...
SURVIVAL | MANAGEMENT | QUALITY | PREDICTORS | VENTRICULAR-ARRHYTHMIA | DISEASE | RISK | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | CARE | OF-LIFE | GERIATRICS & GERONTOLOGY | Coronary Angiography | Heart Failure - therapy | Cardiac Catheterization | Defibrillators, Implantable | Humans | Aged | Clinical Trials as Topic | Cardiac Pacing, Artificial - methods | Pacemaker, Artificial
SURVIVAL | MANAGEMENT | QUALITY | PREDICTORS | VENTRICULAR-ARRHYTHMIA | DISEASE | RISK | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | CARE | OF-LIFE | GERIATRICS & GERONTOLOGY | Coronary Angiography | Heart Failure - therapy | Cardiac Catheterization | Defibrillators, Implantable | Humans | Aged | Clinical Trials as Topic | Cardiac Pacing, Artificial - methods | Pacemaker, Artificial
Journal Article
JACC: Clinical Electrophysiology, ISSN 2405-500X, 2016, Volume 2, Issue 3, pp. 343 - 354
Objectives This study investigated the mechanism of lead malfunction by monitoring lead parameters throughout left ventricular assist device (LVAD)...
ventricular assist device | implantable cardioverter defibrillator
ventricular assist device | implantable cardioverter defibrillator
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A15012 - A15012
IntroductionCoexistence of structural heart disease and His-Purkinje conduction disease in the elderly is high. There is limited data on His bundle pacing...
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 02/2007, Volume 30, Issue 2, pp. 283 - 286
Sustained atrial fibrillation and atrial flutter during pregnancy are uncommon arrhythmias that can significantly complicate normal prenatal care. Direct...
pregnancy electrophysiology | atrial flutter | pharmacology | Pregnancy electrophysiology | Pharmacology | Atrial flutter | FIBRILLATION | ARRHYTHMIAS | FUMARATE | INTRAVENOUS IBUTILIDE | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | CONVERSION | SAFETY | ENGINEERING, BIOMEDICAL | Pregnancy | Pregnancy Complications, Cardiovascular - drug therapy | Sulfonamides - therapeutic use | Atrial Flutter - diagnosis | Humans | Atrial Flutter - drug therapy | Female | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Pregnancy Complications, Cardiovascular - diagnosis | Pregnant women | Atrial fibrillation
pregnancy electrophysiology | atrial flutter | pharmacology | Pregnancy electrophysiology | Pharmacology | Atrial flutter | FIBRILLATION | ARRHYTHMIAS | FUMARATE | INTRAVENOUS IBUTILIDE | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | CONVERSION | SAFETY | ENGINEERING, BIOMEDICAL | Pregnancy | Pregnancy Complications, Cardiovascular - drug therapy | Sulfonamides - therapeutic use | Atrial Flutter - diagnosis | Humans | Atrial Flutter - drug therapy | Female | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Pregnancy Complications, Cardiovascular - diagnosis | Pregnant women | Atrial fibrillation
Journal Article
American Heart Journal, ISSN 0002-8703, 10/2019
Journal Article
Circulation: Arrhythmia and Electrophysiology, ISSN 1941-3149, 12/2014, Volume 7, Issue 6, pp. 1109 - 1115
BACKGROUND—The purpose of this study was to assess whether delayed enhancement (DE) on MRI is associated with ventricular tachycardia (VT)/ventricular...
ventricular tachycardia | delayed enhancement | MRI | sarcoidosis | sudden cardiac death | sarcoid | implantable cardioverter-defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ABNORMALITIES | AMERICAN-COLLEGE | SECONDARY | DEVICE-BASED THERAPY | HEART RHYTHM SOCIETY | COLLABORATION | DISEASE | ASSOCIATION TASK-FORCE | GUIDELINES WRITING COMMITTEE | Predictive Value of Tests | Sarcoidosis - mortality | Ventricular Function, Left | United States | Ventricular Fibrillation - diagnosis | Humans | Middle Aged | Male | Ventricular Dysfunction, Left - mortality | Ventricular Fibrillation - etiology | Cardiomyopathies - physiopathology | Cardiomyopathies - mortality | Cardiomyopathies - diagnosis | Sarcoidosis - physiopathology | Ventricular Fibrillation - physiopathology | Adult | Female | Registries | Retrospective Studies | Severity of Illness Index | Sarcoidosis - diagnosis | Risk Assessment | Risk Factors | Ventricular Fibrillation - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Tachycardia, Ventricular - etiology | Ventricular Dysfunction, Left - etiology | Myocardium - pathology | Ventricular Dysfunction, Left - diagnosis | Ventricular Dysfunction, Left - physiopathology | Stroke Volume | Magnetic Resonance Imaging | Sarcoidosis - complications | Tachycardia, Ventricular - physiopathology | Tachycardia, Ventricular - mortality | Tachycardia, Ventricular - diagnosis | Cardiomyopathies - complications | Aged
ventricular tachycardia | delayed enhancement | MRI | sarcoidosis | sudden cardiac death | sarcoid | implantable cardioverter-defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ABNORMALITIES | AMERICAN-COLLEGE | SECONDARY | DEVICE-BASED THERAPY | HEART RHYTHM SOCIETY | COLLABORATION | DISEASE | ASSOCIATION TASK-FORCE | GUIDELINES WRITING COMMITTEE | Predictive Value of Tests | Sarcoidosis - mortality | Ventricular Function, Left | United States | Ventricular Fibrillation - diagnosis | Humans | Middle Aged | Male | Ventricular Dysfunction, Left - mortality | Ventricular Fibrillation - etiology | Cardiomyopathies - physiopathology | Cardiomyopathies - mortality | Cardiomyopathies - diagnosis | Sarcoidosis - physiopathology | Ventricular Fibrillation - physiopathology | Adult | Female | Registries | Retrospective Studies | Severity of Illness Index | Sarcoidosis - diagnosis | Risk Assessment | Risk Factors | Ventricular Fibrillation - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Tachycardia, Ventricular - etiology | Ventricular Dysfunction, Left - etiology | Myocardium - pathology | Ventricular Dysfunction, Left - diagnosis | Ventricular Dysfunction, Left - physiopathology | Stroke Volume | Magnetic Resonance Imaging | Sarcoidosis - complications | Tachycardia, Ventricular - physiopathology | Tachycardia, Ventricular - mortality | Tachycardia, Ventricular - diagnosis | Cardiomyopathies - complications | Aged
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.